Companies: 10,795·Total market cap: $144.5T

Exact Sciences Corporation

Exact Sciences Corporation

EXASNASDAQHealthcare

$104.91

+$0.00(+0.00%)

Market Cap$20.0B

P/E Ratio—

52W High$104.98

52W Low$38.81

Avg Volume2.5M

Open$104.91

Beta1.44

Net Income Financials Revenue

Exact Sciences Corporation (EXAS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EXAS · net income · updated Jun 8, 2026

Core profitability metrics

EXAS · net income · margin · TTM · CAGR

Net income was −$207.9M for FY2025 (fiscal year ending 2025-12-31), up 79.8% year-over-year. Net profit margin was -6.4%.

FY2025 Net Income−$207.9M▲ +79.8% YoY

Trailing 12M (TTM)−$207.9Mtrailing 4 quarters sum

Net Profit Margin-6.4%−$207.9M ÷ $3.25B

YoY Change+79.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · EXAS net income history · EXAS profit margin

Annual net income data

EXAS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$207.9M▲ +79.8%-6.4%$3.25B

FY2024Loss−$1.03B▼ 404.0%-37.3%$2.76B

FY2023Loss−$204.1M▲ +67.3%-8.2%$2.50B

FY2022Loss−$623.5M▼ 4.7%-29.9%$2.08B

FY2021Loss−$595.6M▲ +27.7%-33.7%$1.77B

Net income vs peers (Healthcare)

EXAS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Exact Sciences CorporationYOU

EXAS

−$207.9M+79.8%-6.4%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Exact Sciences Corporation (EXAS) reported net income of −$207.9M for FY2025 (fiscal year ending 2025-12-31), up 79.8% year-over-year. The net profit margin was -6.4% — meaning the company kept $-0.06 of every dollar of revenue as profit.

Exact Sciences Corporation has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Exact Sciences Corporation's net profit margin was -6.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Exact Sciences Corporation net worth" — the company's market capitalization is a separate figure from EXAS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

EXAS net income · 4 questions

Exact Sciences Corporation is not currently profitable on an annual basis. The company reported a net loss of $207.9M for FY2025.

is EXAS profitabledoes EXAS make a profitEXAS profitabilityEXAS profitable company

▸ Source: FMP /income-statement · GAAP · Exact Sciences Corporation · Exact Sciences Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026